• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    AM Best Affirms Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries

    3/12/25 4:20:00 PM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email

    AM Best has affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long- and Short-Term Issuer Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). Concurrently, AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. The outlook of these Credit Ratings (ratings) is stable. (See link below for a detailed listing of the companies and ratings.)

    The ratings reflect UnitedHealthcare's balance sheet strength, which AM Best assesses as strong, as well as its very strong operating performance, very favorable business profile and very strong enterprise risk management (ERM).

    The rating affirmations of UnitedHealthcare reflect sustained balance sheet strength metrics and a very strong operating performance. The group's risk-adjusted capitalization is at the very strong level, as measured by Best's Capital Adequacy Ratio (BCAR). Capital and surplus growth is supported by retained net earnings in excess of dividends to the parent. UnitedHealthcare actively manages subsidiary risk-adjusted capital on a near- to long-term basis to ensure capital levels are supportive of premium growth. Investment risk is on the low side as the vast majority of assets are held in investment grade fixed income securities and cash/short-term investments with no material exposure to equities, real estate or schedule BA assets. The conservative asset allocation drives strong liquidity measures along with favorable operating cash flows supplemented by internal credit agreements.

    UnitedHealthcare's operating performance is assessed as very strong with a consistent trend of premium growth, which was driven by enrollment gains in most lines of business. Over the past year, all business lines reported an increase in premiums except Medicaid. Medicaid premiums moderated approximately 2 percent over the past year as growth from new contracts mostly offsetting membership losses from state redeterminations of eligibility. Net earnings are mostly driven by favorable underwriting results. The group's investment income remains positive and has shown growth but contributes modestly to overall net earnings. UnitedHealthcare's operating earnings benefit from its large scale with a membership base of 54 million individuals, providing cost advantages for medical expenditures and administrative expenses. UnitedHealthcare's strategic focus is on value-based care and reimbursement models to align provider and payor, which aid in managing medical cost trends and improve outcomes for members.

    UnitedHealthcare holds substantial market share in all lines of business and on a national basis. Premiums and earnings are well-diversified by business segment and geography. A large membership base of 54 million members provides significant economies of scale. Furthermore, the integration of UnitedHealthcare with its affiliate, Optum, affords UnitedHealthcare a competitive advantage in that it provides access to advanced capabilities for cost management, care delivery, pharmacy and innovative technology, and strong data analytics.

    UnitedHealth Group's ERM program is very mature with a well-established framework and governance. This program is dynamic, being used in daily operations and strategic business planning. Conversely, the large scale of the organization and numerous acquisitions exposes it to material business and reputational risks. Future growth could be challenged by federal and state agencies.

    UnitedHealth Group has strong financial flexibility with material non-regulated operating cash flows from its Optum operations. Equity has shown consistent growth over the past five years, driven entirely by retained earnings despite large share repurchases and growing dividend programs. Strong liquidity is driven by favorable operating cash flows, parent company cash, a commercial paper program and a $21 billion revolving credit facility. Financial leverage at year-end 2024 was elevated at 43.7%, as measured by BCAR, and is above the company's long-term target of 40%. Additionally, earnings before interest and tax coverage remain good but declined in 2024 to about eight times. Furthermore, UnitedHealth Group had a large amount of goodwill and intangibles on the balance sheet totaling approximately 132% of equity. There has been no history of any material impairments and acquired assets continue to contribute favorably to revenues and earnings.

    UnitedHealth Group's operating performance declined materially in 2024, due to $2 billion in direct expenses related to the Change Healthcare cyber breach and $8.3 billion non-cash loss on the sale of its South American business. Core business segments have performed well, although margins on the health business have been under pressure due to medical costs, utilization trends and specialty pharmacy costs. Revenue and earnings growth are expected to return to historical trends in the near term. The company has significant scale and is well-diversified between business segments in its insurance operations, as well as within its non-regulated Optum healthcare service businesses. However, government programs have become a large portion of insurance revenue and earnings.

    A complete listing of UnitedHealth Group Incorporated and its subsidiaries' FSRs, Long-Term ICRs and Long-Term IRs also is available.

    This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments.

    AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

    Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250312620180/en/

    Bridget Maehr

    Director

    +1 908 882 2080

    [email protected]

    Sally Rosen

    Senior Director

    +1 908 882 2284

    [email protected]

    Christopher Sharkey

    Associate Director, Public Relations

    +1 908 882 2310

    [email protected]

    Al Slavin

    Senior Public Relations Specialist

    +1 908 882 2318

    [email protected]

    Get the next $UNH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    7/31/2025$198.00Neutral → Underperform
    Robert W. Baird
    7/30/2025$400.00 → $325.00Outperform
    Oppenheimer
    6/11/2025$312.00Outperform → Neutral
    Robert W. Baird
    5/21/2025$270.00Hold → Reduce
    HSBC Securities
    5/19/2025$308.00Buy → Hold
    TD Cowen
    5/14/2025Strong Buy → Mkt Perform
    Raymond James
    5/14/2025$350.00Buy → Neutral
    BofA Securities
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    More analyst ratings

    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UnitedHealth downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded UnitedHealth from Neutral to Underperform and set a new price target of $198.00

    7/31/25 7:58:50 AM ET
    $UNH
    Medical Specialities
    Health Care

    Oppenheimer reiterated coverage on UnitedHealth with a new price target

    Oppenheimer reiterated coverage of UnitedHealth with a rating of Outperform and set a new price target of $325.00 from $400.00 previously

    7/30/25 7:58:05 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded UnitedHealth from Outperform to Neutral and set a new price target of $312.00

    6/11/25 7:46:38 AM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    SEC Filings

    View All

    SEC Form S-8 filed by UnitedHealth Group Incorporated

    S-8 - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    8/14/25 4:45:48 PM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form 10-Q filed by UnitedHealth Group Incorporated

    10-Q - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    8/11/25 4:20:29 PM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Incorporated filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    7/31/25 5:08:18 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Twilio Set to Join S&P MidCap 400

    NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE:TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE:UNH) acquired Amedisys in a deal completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector August 19, 2025 S&P MidCap 400 Addition Twilio TWLO Information Technology August 19, 2025 S&P MidCap 400 Deletion Amedisys AMED Health Care For more information about S&P Dow Jones Indices, please visit www.spdji

    8/14/25 6:08:00 PM ET
    $AMED
    $SPGI
    $TWLO
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

    The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.21 per share, to be paid on September 23, 2025, to all shareholders of record of UNH common stock as of the close of business September 15, 2025. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range o

    8/13/25 6:50:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Announces Changes to Leadership Team

    UnitedHealth Group (NYSE:UNH) today announced Wayne S. DeVeydt has been appointed its chief financial officer, effective September 2, 2025. John F. Rex, who joined the company in 2012 and has been CFO since 2016, will become strategic advisor to the CEO on the same date. "Wayne DeVeydt combines deep financial acumen and operating experience with the mission-oriented and compassionate approach to health care that is a perfect fit for UnitedHealth Group," said Stephen J. Hemsley, company chairman and chief executive officer. "John Rex has been an exceptional leader, having helped guide our company through substantial change with both strategic vision and strong commitment to our mission,"

    7/31/25 5:06:00 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 6:11:47 PM ET
    $UNH
    Medical Specialities
    Health Care

    CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 6:11:45 PM ET
    $UNH
    Medical Specialities
    Health Care

    Director Flynn Timothy Patrick bought $491,786 worth of shares (1,533 units at $320.80) (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 12:28:22 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, UHG Hemsley Stephen J was granted 198 shares, increasing direct ownership by 0.05% to 374,606 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    7/2/25 4:09:18 PM ET
    $UNH
    Medical Specialities
    Health Care

    Director Hooper Michele J was granted 173 shares, increasing direct ownership by 0.43% to 40,479 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    7/2/25 4:09:02 PM ET
    $UNH
    Medical Specialities
    Health Care

    Director Flynn Timothy Patrick was granted 288 shares, increasing direct ownership by 3% to 9,477 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    7/2/25 4:09:10 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/13/24 5:16:09 PM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/9/24 10:05:20 AM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/9/23 12:39:51 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Financials

    Live finance-specific insights

    View All

    UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

    The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.21 per share, to be paid on September 23, 2025, to all shareholders of record of UNH common stock as of the close of business September 15, 2025. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range o

    8/13/25 6:50:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Re-Establishes Full Year Outlook and Reports Second Quarter 2025 Results

    Full Year 2025 Revenue Outlook of $445.5 Billion to $448.0 Billion Full Year 2025 Earnings Outlook of at least $14.65 Per Share, Adjusted Earnings of at least $16.00 Per Share Second Quarter Earnings were $3.74 Per Share, Adjusted Earnings were $4.08 Per Share UnitedHealth Group (NYSE:UNH) reported second quarter 2025 results and updated its 2025 outlook. "UnitedHealth Group has embarked on a rigorous path back to being a high-performing company fully serving the health needs of individuals and society broadly," said Stephen Hemsley, chief executive officer of UnitedHealth Group. "As we strengthen operating disciplines, positioning us for growth in 2026 and beyond, the people at

    7/29/25 5:55:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    AM Best Assigns Issue Credit Ratings to UnitedHealth Group Incorporated's New Senior Unsecured Notes

    AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IRs) of "a" (Excellent) to UnitedHealth Group Incorporated's (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) recently issued senior unsecured notes. (See detailed list below.) The outlook assigned to these Credit Ratings (ratings) is negative. The proceeds from UnitedHealth Group's recent $3 billion debt issuance are expected to be used for general corporate purposes, including repayment of short-term borrowings, commercial paper and/or upcoming debt maturities. As of May 31, 2025, UnitedHealth Group had approximately $12.7 billion of short-term borrowings outstanding. Financial leverage at the end of first quarter 2025 was e

    6/23/25 4:57:00 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Leadership Updates

    Live Leadership Updates

    View All

    Twilio Set to Join S&P MidCap 400

    NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE:TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE:UNH) acquired Amedisys in a deal completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector August 19, 2025 S&P MidCap 400 Addition Twilio TWLO Information Technology August 19, 2025 S&P MidCap 400 Deletion Amedisys AMED Health Care For more information about S&P Dow Jones Indices, please visit www.spdji

    8/14/25 6:08:00 PM ET
    $AMED
    $SPGI
    $TWLO
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    UnitedHealth Group Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.

    Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr

    5/13/25 5:59:56 PM ET
    $UNH
    Medical Specialities
    Health Care

    Charlie Baker Joins UnitedHealth Group's Board of Directors

    UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos

    11/3/23 4:00:00 PM ET
    $UNH
    Medical Specialities
    Health Care